Pancreatic Cancer Research

ResearcherChinese University of Hong KongActive in the last 2 years

Yangchao Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0249-3414; OpenAlex author ID A5055280421. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 13)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 5 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 15

  1. Genome-Wide and Multi-Omics Analysis Identified DNA-Interacting Circular RNA circFOXK2 as MLL1 Regulator for Histone H3K4 Methylation in Pancreatic Ductal Aden… Last author DOI 10.1002/advs.77107↗
  2. Exosomal CircGANAB promotes cancer progression and immunotherapy resistance by degrading interacting RNAs and limiting T cell infiltration in pancreatic ductal… Last author DOI 10.1016/j.drup.2026.101416↗
  3. Labdane-type diterpenoids from Hypoestes phyllostachya inhibit pancreatic cancer stem cells. Co-author DOI 10.1016/j.phytochem.2025.114650↗
  4. The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma. Last author DOI 10.1111/cas.16286↗
  5. Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s40364-023-00514-4↗
  6. CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein. Last author DOI 10.1186/s12943-021-01481-w↗
  7. Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.canlet.2020.02.038↗
  8. LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.jcmgh.2020.06.009↗
  9. A simple and rapid colorimetric detection of serum lncRNA biomarkers for diagnosis of pancreatic cancer. Last author DOI 10.1039/c9ra07858d↗
  10. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942. Last author DOI 10.1158/0008-5472.can-19-3268↗
  11. Histone demethylase JMJD3 disrupts spectrin-dependent cytoskeleton in Pancreatic Ductal Adenocarcinoma cells by regulating H exokinase domain containing 1 expr… Last author DOI 10.21203/rs.3.rs-30041/v1↗
  12. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma. Last author DOI 10.1002/ijc.30414↗
  13. Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer. Last author DOI 10.3748/wjg.v22.i31.7046↗
  14. Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective. First author DOI 10.3748/wjg.v22.i33.7463↗
  15. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Last author DOI 10.1053/j.gastro.2013.01.058↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chi Hin Wong · 10 shared papers, 2016–2026 · strength 1.87
  2. Stephen Lam Chan · 5 shared papers, 2013–2024 · strength 0.67
  3. Chi Han Li · 5 shared papers, 2013–2024 · strength 0.59
  4. Ut Kei Lou · 3 shared papers, 2020–2022 · strength 0.48
  5. Yinxin Zhu · 4 shared papers, 2013–2023 · strength 0.44
  6. Ksh Chok · 1 shared paper, 2026 · strength 0.36
  7. Yan‐Fang Xian · 1 shared paper, 2026 · strength 0.29
  8. Michael Anthony Hollingsworth · 1 shared paper, 2026 · strength 0.29
  9. Huiyi Feng · 2 shared papers, 2016–2020 · strength 0.23
  10. Bo Li · 1 shared paper, 2024 · strength 0.23
  11. Yuting Liu · 1 shared paper, 2024 · strength 0.23
  12. Lin‐Fen Ding · 1 shared paper, 2025 · strength 0.22
  13. Xing‐De Wu · 1 shared paper, 2025 · strength 0.22
  14. Tong Yan · 1 shared paper, 2025 · strength 0.22
  15. Zhangang Xiao · 3 shared papers, 2013–2020 · strength 0.22
  16. Jiatong Wang · 1 shared paper, 2023 · strength 0.19
  17. Guolin Li · 1 shared paper, 2020 · strength 0.11
  18. Rufu Chen · 1 shared paper, 2020 · strength 0.11
  19. Chi‐Han Li · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.